The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
Open accessAbstract
Purpose: Genetic testing for breast cancer risk is evolving rapidly, with growing use of multiple-gene panels that can yield uncertain results. However, little is known about the context of such testing or its impact on treatment. Methods: A population-based sample of patients with breast cancer diagnosed in 2014 to 2015 and identified by two SEER registries (Georgia and Los Angeles) were surveyed about genetic testing experiences (N = 3,672; response rate, 68%). Responses were merged with SEER data. A patient subgroup at higher pretest risk of pathogenic mutation carriage was defined according to genetic testing guidelines. Patients’ attending surgeons were surveyed about genetic testing and results management. We examined patterns and correlates of genetic counseling and testing and the impact of results on bilateral mastectomy (BLM) use. Results: Six hundred sixty-six patients reported genetic testing. Although two thirds of patients were tested before surgical treatment, patients without private insurance more often experienced delays. Approximately half of patients (57% at higher pretest risk, 42% at average risk) discussed results with a genetic counselor. Patients with pathogenic mutations in BRCA1/2 or another gene had the highest rates of BLM (higher risk, 80%; average risk, 85%); however, BLM was also common among patients with genetic variants of uncertain significance (VUS; higher risk, 43%; average risk, 51%). Surgeons’ confidence in discussing testing increased with volume of patients with breast cancer, but many surgeons (higher volume, 24%; lower volume, 50%) managed patients with BRCA1/2 VUS the same as patients with BRCA1/2 pathogenic mutations. Conclusion: Many patients with breast cancer are tested without ever seeing a genetic counselor. Half of average-risk patients with VUS undergo BLM, suggesting a limited understanding of results that some surgeons share. These findings emphasize the need to address challenges in personalized communication about genetic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Internet, Mail, and Mixed-Mode Surveys: The Tailored Design Method
Dillman, D. A., Smyth, J. D., & Christian, L. M. (2008) · Cited by 5,345
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171
Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 934
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Easton, D. F., Pharoah, P. D. P., Antoniou, A. C., Tischkowitz, M., Tavtigian, S. V., Nathanson, K. L., Devilee, P., Meindl, A., Couch, F. J., Southey, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1501341 · Cited by 920
Couch, F. J., Hart, S. N., Sharma, P., Toland, A. E., Wang, X., Miron, P., Olson, J. E., Godwin, A. K., Pankratz, V. S., Olswold, C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.1414 · Cited by 672
Tuttle, T. M., Habermann, E. B., Grund, E. H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3141 · Cited by 661
Tung, N., Lin, N. U., Kidd, J., Allen, B. A., Singh, N., Wenstrup, R. J., Hartman, A.-R., Winer, E. P., & Garber, J. E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.0747 · Cited by 556
Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S., McGuire, V., Ladabaum, U., Kobayashi, Y., Lincoln, S. E., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6607 · Cited by 485
Self-citationRobson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0660 · Cited by 421
Desmond, A., Kurian, A. W., Gabree, M., Mills, M. A., Anderson, M. J., Kobayashi, Y., Horick, N., Yang, S., Shannon, K. M., Tung, N., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2690 · Cited by 333
Self-citationLaDuca, H., Stuenkel, A. J., Dolinsky, J. S., Keiles, S., Tandy, S., Pesaran, T., Chen, E., Gau, C.-L., Palmaer, E., Shoaepour, K., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.40 · Cited by 332
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015
Daly, M. B., Pilarski, R., Axilbund, J. E., Berry, M., Buys, S. S., Crawford, B., Farmer, M., Friedman, S., Garber, J. E., Khan, S., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0018 · Cited by 292
Self-citationRosenberg, S. M., Tracy, M. S., Meyer, M. E., Sepucha, K., Gelber, S., Hirshfield-Bartek, J., Troyan, S., Morrow, M., Schapira, L., Come, S. E., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-00003 · Cited by 265
Self-citationKurian, A. W., Lichtensztajn, D. Y., Keegan, T. H. M., Nelson, D. O., Clarke, C. A., & Gomez, S. L. (2014) · JAMA · doi:10.1001/jama.2014.10707 · Cited by 255
Self-citationPhysicians' Attitudes About Multiplex Tumor Genomic Testing
Gray, S. W., Hicks-Courant, K., Cronin, A., Rollins, B. J., & Weeks, J. C. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.4298 · Cited by 241
Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?
Domchek, S. M., Bradbury, A., Garber, J. E., Offit, K., & Robson, M. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.9403 · Cited by 237
Social and Clinical Determinants of Contralateral Prophylactic Mastectomy
Hawley, S. T., Jagsi, R., Morrow, M., Janz, N. K., Hamilton, A., Graff, J. J., & Katz, S. J. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.5689 · Cited by 183
Self-citationPanel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
Thompson, E. R., Rowley, S. M., Li, N., McInerny, S., Devereux, L., Wong-Brown, M. W., Trainer, A. H., Mitchell, G., Scott, R. J., James, P. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.7454 · Cited by 183
A systematic review of factors that act as barriers to patient referral to genetic services
Delikurt, T., Williamson, G. R., Anastasiadou, V., & Skirton, H. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.180 · Cited by 180
Balmaña, J., Digiovanni, L., Gaddam, P., Walsh, M. F., Joseph, V., Stadler, Z. K., Nathanson, K. L., Garber, J. E., Couch, F. J., Offit, K., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.4316 · Cited by 174
Maxwell, K. N., Wubbenhorst, B., D’Andrea, K., Garman, B., Long, J. M., Powers, J., Rathbun, K., Stopfer, J. E., Zhu, J., Bradbury, A. R., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.176 · Cited by 159
Effect of Genetic Cancer Risk Assessment on Surgical Decisions at Breast Cancer Diagnosis
Weitzel, J. N. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.12.1323 · Cited by 150
Cancer Genomics and Inherited Risk
Stadler, Z. K., Schrader, K. A., Vijai, J., Robson, M. E., & Offit, K. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.7271 · Cited by 149
Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer
Kurian, A. W., Griffith, K. A., Hamilton, A. S., Ward, K. C., Morrow, M., Katz, S. J., & Jagsi, R. (2017) · JAMA · doi:10.1001/jama.2016.16918 · Cited by 146
Self-citationExpanding Access to BRCA1/2 Genetic Counseling with Telephone Delivery: A Cluster Randomized Trial
Kinney, A. Y., Butler, K. M., Schwartz, M. D., Mandelblatt, J. S., Boucher, K. M., Pappas, L. M., Gammon, A., Kohlmann, W., Edwards, S. L., Stroup, A. M., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju328 · Cited by 116
Evans, D. G., Wisely, J. A., Clancy, T., Lalloo, F. I., Wilson, M., Johnson, R. J., Duncan, J., Barr, L. C., Gandhi, A., & Howell, A. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0650-8 · Cited by 106
Jagsi, R., Griffith, K. A., Kurian, A. W., Morrow, M., Hamilton, A. S., Graff, J. J., Katz, S. J., & Hawley, S. T. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.5885 · Cited by 105
Self-citationHamilton, A. S., Hofer, T. P., Hawley, S. T., Morrell, D., Leventhal, M., Deapen, D., Salem, B., & Katz, S. J. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0238 · Cited by 103
Self-citationBradbury, A. R., Patrick‐Miller, L. J., Long, J. M., Powers, J. M., Stopfer, J. E., Forman, A. D., Rybak, C., Mattie, K. D., Brandt, A. C., Chambers, R., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.134 · Cited by 91
Multigene Panel Testing in Oncology Practice: How Should We Respond?
Kurian, A. W., & Ford, J. M. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.28 · Cited by 78
Self-citationGene Patents and Personalized Cancer Care: Impact of the Myriad Case on Clinical Oncology
Offit, K., Bradbury, A. R., Storm, C. D., Merz, J. F., Noonan, K. E., & Spence, R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.7388 · Cited by 63
Cancer Information Seeking in the Digital Age
Noar, S. M., Althouse, B. M., Ayers, J. W., Francis, D. B., & Ribisl, K. M. (2014) · Medical Decision Making · doi:10.1177/0272989x14556130 · Cited by 60
Genetic Cancer Susceptibility Testing: Increased Technology, Increased Complexity
Yu, P. P., Vose, J. M., & Hayes, D. F. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.3628 · Cited by 42
Second Opinions From Medical Oncologists for Early-Stage Breast Cancer
Kurian, A. W., Friese, C. R., Bondarenko, I., Jagsi, R., Li, Y., Hamilton, A. S., Ward, K. C., & Katz, S. J. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5652 · Cited by 30
Self-citationMoreno, L., Linossi, C., Esteban, I., Gadea, N., Carrasco, E., Bonache, S., Gutiérrez‐Enríquez, S., Cruz, C., Díez, O., & Balmañà, J. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1470-0 · Cited by 24
Cited by
Hu, C., Hart, S. N., Polley, E. C., Gnanaolivu, R., Shimelis, H., Lee, K. Y., Lilyquist, J., Na, J., Moore, R., Antwi, S. O., et al. (2018) · JAMA · doi:10.1001/jama.2018.6228 · Cited by 577
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Pashayan, N., Antoniou, A. C., Ivanus, U., Esserman, L. J., Easton, D. F., French, D., Sroczynski, G., Hall, P., Cuzick, J., Evans, D. G., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0388-9 · Cited by 438
Kurian, A. W., Ward, K. C., Howlader, N., Deapen, D., Hamilton, A. S., Mariotto, A., Miller, D., Penberthy, L. S., & Katz, S. J. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01854 · Cited by 387
Self-citationNational Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer
Childers, C. P., Childers, K. K., Maggard-Gibbons, M., & Macinko, J. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.6314 · Cited by 351
Samadder, N. J., Riegert-Johnson, D., Boardman, L., Rhodes, D., Wick, M., Okuno, S., Kunze, K. L., Golafshar, M., Uson, P. L. S., Mountjoy, L., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.6252 · Cited by 304
Metadata
- Authors
- Kurian, A. W., Li, Y., Hamilton, A. S., Ward, K. C., Hawley, S. T., Morrow, M., McLeod, M. C., Jagsi, R., & Katz, S. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2017-07-10
- Volume
- 35
- Issue
- 20
- Pages
- 2232-2239
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2605654091
- Cited by
- 265
- References
- 37
- FWCI
- 22.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.